Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06502067

Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery

To study the efficiacy of serratus posterior superior block in controlling perioperative breast cancer surgery pain and its effect on inflamatory markers.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Back ground The presence of pain during the initial course of treatment in women with early-stage breast cancer was associated with significantly higher levels of c-reactive protein(CRP) ,interleukin-7(IL-7)and interleukin-13(IL-13) There is evidence of effectiveness of regional block in controlling inflamatory markers Serratus posterior superior intercostal plane block (SPSIPB) is a novel Regional technique that provides analgesia in the hemithorax, shoulder, and back of the neck which proved its efficacy in controlling pain after Video assisted thoracoscopic surgery there are little epidemiological data on (SPSIPB)usage in masectomy and lumpectomy procedures and its effect on inflamatory markers

Methodology:

  • Type of the Study: Randomized prospective comparative controlled double-blinded study
  • Study Setting: Ain Shams University Hospitals
  • Study Period: One year after approval of the protocol.
  • Place :Ain shams university hospitals
  • Study Population: Adult patients who will undergo breast cancer surgey.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults undergoing unilateral breast surgery under general anesthesia
  • Age 21 to 60 years with body mass index (BMI)=18 to 25 kg/m2
  • American Society of Anesthesiologists (ASA) grade I-III.

Exclusion criteria

  • Patients with Long-time use of analgesic drugs
  • Past history of chest surgery,
  • Allergy to local anesthetics,
  • Systemic infection,
  • Cognitive and language disorders precluding participation,
  • Patients with coagulopathy,anticoagulant users
  • hemodynamic unstable patients
  • Patients with neurology, spinal, psychiatry diseases
  • infection at block site
  • patients refused to participate in the study .

Treatment and study plan

Analgesia mangement group A,B

Drug

1gm of paracetamol, 30mg of ketorolac and 1mg Granitryl will be given twenty minutes before the end of the operation .

Primary outcomes

  1. is to calculate total perioperative analgesia consumption throughout (24hours).

    Time frame: 24 hour postoperative

Study contacts

Contact information is provided by the study sponsor or research team.

Dalia Mostafa Ghazy, Master degree

CONTACT

[email protected]

01060192709

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Efficacy of Serratus Posterior Superior Intercostal Plane Block (SPSIPB) on Perioperative Analgesia and Inflamatory Markers in Breast Surgery

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 15, 2024
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.